BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han Q, Zhao H, Jiang Y, Yin C, Zhang J. HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape. Cells. 2019;8. [PMID: 31181729 DOI: 10.3390/cells8060558] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Xue D, Han J, Liang Z, Jia L, Liu Y, Tuo H, Peng Y. Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma. JHC 2022;Volume 9:99-112. [DOI: 10.2147/jhc.s351038] [Reference Citation Analysis]
2 Gu WJ, Shen YW, Zhang LJ, Zhang H, Nagle DG, Luan X, Liu SH. The multifaceted involvement of exosomes in tumor progression: Induction and inhibition. MedComm (2020) 2021;2:297-314. [PMID: 34766148 DOI: 10.1002/mco2.49] [Reference Citation Analysis]
3 Srivastava A, Amreddy N, Pareek V, Chinnappan M, Ahmed R, Mehta M, Razaq M, Munshi A, Ramesh R. Progress in extracellular vesicle biology and their application in cancer medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1621. [PMID: 32131140 DOI: 10.1002/wnan.1621] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
4 Tang Q, Li X, Chen Y, Long S, Yu Y, Sheng H, Wang S, Han L, Wu W. Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP-TUG1/miR-4726-5p/MUC1 pathway. Mol Carcinog 2022. [PMID: 35040191 DOI: 10.1002/mc.23389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lin H, Peng J, Zhu T, Xiong M, Zhang R, Lei L. Exosomal miR-4800-3p Aggravates the Progression of Hepatocellular Carcinoma via Regulating the Hippo Signaling Pathway by Targeting STK25. Front Oncol 2022;12:759864. [PMID: 35756606 DOI: 10.3389/fonc.2022.759864] [Reference Citation Analysis]
6 Li L, Xiao F, Liu G, Chen Y, Xu Y. Serum Exosomal lncRNA AC007099.1 Regulates the Expression of Neuropeptide-Related FAP, as a Potential Biomarker for Hepatocarcinogenesis. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/9501008] [Reference Citation Analysis]
7 Zhang D, Zhang Y, Zhang X, Zhai H, Sun X, Li Y. Circ_0046600 promotes hepatocellular carcinoma progression via up-regulating SERBP1 through sequestering miR-1258. Pathol Res Pract 2021;228:153681. [PMID: 34784519 DOI: 10.1016/j.prp.2021.153681] [Reference Citation Analysis]
8 Zelli V, Compagnoni C, Capelli R, Corrente A, Di Vito Nolfi M, Zazzeroni F, Alesse E, Tessitore A. Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma. Front Oncol 2022;12:940056. [DOI: 10.3389/fonc.2022.940056] [Reference Citation Analysis]
9 Liu J, Jiang M, Jin Q, Wu YL, Cui ZY, Cui BW, Shang Y, Zhan ZY, Lin YC, Jiao JY, Piao MH, Zhang ZH, Sun RH, Nan JX, Lian LH. Modulation of HMGB1 Release in APAP-Induced Liver Injury: A Possible Strategy of Chikusetsusaponin V Targeting NETs Formation. Front Pharmacol 2021;12:723881. [PMID: 34366873 DOI: 10.3389/fphar.2021.723881] [Reference Citation Analysis]
10 Zhang L, Kuca K, You L, Zhao Y, Musilek K, Nepovimova E, Wu Q, Wu W, Adam V. Signal transducer and activator of transcription 3 signaling in tumor immune evasion. Pharmacol Ther 2021;:107969. [PMID: 34450232 DOI: 10.1016/j.pharmthera.2021.107969] [Reference Citation Analysis]
11 Hussain MWA, Jahangir S, Ghosh B, Yesmin F, Anis A, Satil SN, Anwar F, Rashid MH. Exosomes for Regulation of Immune Responses and Immunotherapy. JNT 2022;3:55-85. [DOI: 10.3390/jnt3010005] [Reference Citation Analysis]
12 Ma C, Chen H, Zhang S, Yan Y, Wu R, Wang Y, Liu Y, Yang L, Liu M. Exosomal and extracellular HMGB1 have opposite effects on SASH1 expression in rat astrocytes and glioma C6 cells. Biochem Biophys Res Commun 2019;518:325-30. [PMID: 31421824 DOI: 10.1016/j.bbrc.2019.08.057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
13 Qiu LW, Liu YF, Cao XQ, Wang Y, Cui XH, Ye X, Huang SW, Xie HJ, Zhang HJ. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment. World J Gastroenterol 2020; 26(18): 2126-2137 [PMID: 32476780 DOI: 10.3748/wjg.v26.i18.2126] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
14 Wang S, Gao S, Zhou D, Qian X, Luan J, Lv X. The role of the CD39-CD73-adenosine pathway in liver disease. J Cell Physiol 2021;236:851-62. [PMID: 32648591 DOI: 10.1002/jcp.29932] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
15 Melnik BC. Dairy consumption and hepatocellular carcinoma risk. Ann Transl Med 2021;9:736. [PMID: 33987434 DOI: 10.21037/atm-2020-ubih-06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Baldari S, Di Rocco G, Magenta A, Picozza M, Toietta G. Extracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation. Cells 2019;8:E1560. [PMID: 31816923 DOI: 10.3390/cells8121560] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
17 Zeng F, Zhang Y, Han X, Zeng M, Gao Y, Weng J. Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma. Comput Struct Biotechnol J 2021;19:2775-89. [PMID: 34093992 DOI: 10.1016/j.csbj.2021.03.033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 You X, Sun W, Wang Y, Liu X, Wang A, Liu L, Han S, Sun Y, Zhang J, Guo L, Zhang Y. Cervical cancer-derived exosomal miR-663b promotes angiogenesis by inhibiting vinculin expression in vascular endothelial cells. Cancer Cell Int 2021;21:684. [PMID: 34923985 DOI: 10.1186/s12935-021-02379-9] [Reference Citation Analysis]
19 Feng K, Ma R, Zhang L, Li H, Tang Y, Du G, Niu D, Yin D. The Role of Exosomes in Thyroid Cancer and Their Potential Clinical Application. Front Oncol 2020;10:596132. [PMID: 33335859 DOI: 10.3389/fonc.2020.596132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Meng W, He C, Hao Y, Wang L, Li L, Zhu G. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source. Drug Deliv 2020;27:585-98. [PMID: 32264719 DOI: 10.1080/10717544.2020.1748758] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 52.0] [Reference Citation Analysis]
21 Li X, Chen R, Kemper S, Brigstock DR. Structural and Functional Characterization of Fibronectin in Extracellular Vesicles From Hepatocytes. Front Cell Dev Biol 2021;9:640667. [PMID: 33816490 DOI: 10.3389/fcell.2021.640667] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Liu Y, Shi K, Chen Y, Wu X, Chen Z, Cao K, Tao Y, Chen X, Liao J, Zhou J. Exosomes and Their Role in Cancer Progression. Front Oncol 2021;11:639159. [PMID: 33828985 DOI: 10.3389/fonc.2021.639159] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Wu Z, Li C, Zhang Y, Lin R. Bioinformatics Study Revealed Significance of Exosome Transcriptome in Hepatocellular Carcinoma Diagnosis. Front Cell Dev Biol 2022;10:813701. [DOI: 10.3389/fcell.2022.813701] [Reference Citation Analysis]
24 Zhong X, Zhou Y, Cao Y, Ding J, Wang P, Luo Y, Liu H, Zhu Z, Jing X. Enhanced antitumor efficacy through microwave ablation combined with a dendritic cell-derived exosome vaccine in hepatocellular carcinoma. Int J Hyperthermia 2020;37:1210-8. [PMID: 33100037 DOI: 10.1080/02656736.2020.1836406] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
25 Feng H, Wei X, Pang L, Wu Y, Hu B, Ruan Y, Liu Z, Liu J, Wang T. Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer. Front Mol Biosci 2020;7:189. [PMID: 33088807 DOI: 10.3389/fmolb.2020.00189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Jiang J, Mei J, Yi S, Feng C, Ma Y, Liu Y, Liu Y, Chen C. Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery. Adv Drug Deliv Rev 2022;180:114046. [PMID: 34767863 DOI: 10.1016/j.addr.2021.114046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Crow J, Samuel G, Godwin AK. Beyond tumor mutational burden: potential and limitations in using exosomes to predict response to immunotherapy. Expert Rev Mol Diagn 2019;19:1079-88. [PMID: 31687863 DOI: 10.1080/14737159.2020.1688144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
28 Dou CZ, Liu YF, Zhang LL, Chen SH, Hu CY, Liu Y, Zhao YT. Polyphenols from Broussonetia papyrifera Induce Apoptosis of HepG2 Cells via Inactivation of ERK and AKT Signaling Pathways. Evid Based Complement Alternat Med 2021;2021:8841706. [PMID: 33884026 DOI: 10.1155/2021/8841706] [Reference Citation Analysis]
29 Jia Z, Jia J, Yao L, Li Z. Crosstalk of Exosomal Non-Coding RNAs in The Tumor Microenvironment: Novel Frontiers. Front Immunol 2022;13:900155. [PMID: 35663957 DOI: 10.3389/fimmu.2022.900155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Hosseini R, Asef-Kabiri L, Yousefi H, Sarvnaz H, Salehi M, Akbari ME, Eskandari N. The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells. Mol Cancer 2021;20:83. [PMID: 34078376 DOI: 10.1186/s12943-021-01376-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Huang Y, Luo W, Chen S, Su H, Zhu W, Wei Y, Qiu Y, Long Y, Shi Y, Wei J. Association of a Novel DOCK2 Mutation-Related Gene Signature With Immune in Hepatocellular Carcinoma. Front Genet 2022;13:872224. [PMID: 35620462 DOI: 10.3389/fgene.2022.872224] [Reference Citation Analysis]
32 Qin L, Zhan Z, Wei C, Li X, Zhang T, Li J. Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer. Mol Med Rep 2021;23:421. [PMID: 33864660 DOI: 10.3892/mmr.2021.12060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Słomka A, Mocan T, Wang B, Nenu I, Urban SK, Gonzales-Carmona M, Schmidt-Wolf IGH, Lukacs-Kornek V, Strassburg CP, Spârchez Z, Kornek M. EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC. Cancers (Basel) 2020;12:E3019. [PMID: 33080904 DOI: 10.3390/cancers12103019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
34 Pascut D, Pratama MY, Vo NVT, Masadah R, Tiribelli C. The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications. Cancers (Basel) 2020;12:E823. [PMID: 32235370 DOI: 10.3390/cancers12040823] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
35 Huang H, Hu Y, Guo L, Wen Z. Integrated bioinformatics analyses of key genes involved in hepatocellular carcinoma immunosuppression. Oncol Lett 2021;22:830. [PMID: 34691257 DOI: 10.3892/ol.2021.13091] [Reference Citation Analysis]
36 Tang Y, Jiang M, Jiang HM, Ye ZJ, Huang YS, Li XS, Qin BY, Zhou RS, Pan HF, Zheng DY. The Roles of circRNAs in Liver Cancer Immunity. Front Oncol 2020;10:598464. [PMID: 33614486 DOI: 10.3389/fonc.2020.598464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Ding H, Fan GL, Yi YX, Zhang W, Xiong XX, Mahgoub OK. Prognostic Implications of Immune-Related Genes' (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer. Front Genet 2020;11:725. [PMID: 32793281 DOI: 10.3389/fgene.2020.00725] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
38 Zhu J, Tang B, Gao Y, Xu S, Tu J, Wang Y, Yang W, Fang S, Weng Q, Zhao Z, Xu M, Yang Y, Chen M, Lu C, Ji J. Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2. J Inflamm Res 2021;14:4089-109. [PMID: 34466015 DOI: 10.2147/JIR.S315957] [Reference Citation Analysis]
39 Xie F, Xu M, Lu J, Mao L, Wang S. The role of exosomal PD-L1 in tumor progression and immunotherapy. Mol Cancer 2019;18:146. [PMID: 31647023 DOI: 10.1186/s12943-019-1074-3] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 25.7] [Reference Citation Analysis]
40 Rahmani A, Saleki K, Javanmehr N, Khodaparast J, Saadat P, Nouri HR. Mesenchymal stem cell-derived extracellular vesicle-based therapies protect against coupled degeneration of the central nervous and vascular systems in stroke. Ageing Res Rev 2020;62:101106. [PMID: 32565329 DOI: 10.1016/j.arr.2020.101106] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
41 Gao Q, Liu HT, Xu YQ, Zhang L, Liu YR, Ren Q, Sheng JP, Zhang ZX. Serum-derived exosomes promote CD8+ T cells to overexpress PD-1, affecting the prognosis of hypopharyngeal carcinoma. Cancer Cell Int 2021;21:584. [PMID: 34717645 DOI: 10.1186/s12935-021-02294-z] [Reference Citation Analysis]
42 Liu C, Wang Y, Li L, He D, Chi J, Li Q, Wu Y, Zhao Y, Zhang S, Wang L, Fan Z, Liao Y. Engineered extracellular vesicles and their mimetics for cancer immunotherapy. J Control Release 2022;349:679-98. [PMID: 35878728 DOI: 10.1016/j.jconrel.2022.05.062] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Wang LP, Lin J, Ma XQ, Xu DY, Shi CF, Wang W, Jiang XJ. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis. J Exp Clin Cancer Res 2021;40:177. [PMID: 34039401 DOI: 10.1186/s13046-021-01973-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
44 Ye L, Zhu Z, Chen X, Zhang H, Huang J, Gu S, Zhao X. The Importance of Exosomal PD-L1 in Cancer Progression and Its Potential as a Therapeutic Target. Cells 2021;10:3247. [PMID: 34831468 DOI: 10.3390/cells10113247] [Reference Citation Analysis]
45 Xue D, Han J, Liu Y, Tuo H, Peng Y. Current perspectives on exosomes in the diagnosis and treatment of hepatocellular carcinoma (review). Cancer Biol Ther 2021;22:279-90. [PMID: 33847207 DOI: 10.1080/15384047.2021.1898728] [Reference Citation Analysis]
46 Wang L, Yang J, Huang J, Wen ZQ, Xu N, Liu X, Zhang JH, Li WL. miRNA Expression Profile in the N2 Phenotype Neutrophils of Colorectal Cancer and Screen of Putative Key miRNAs. Cancer Manag Res 2020;12:5491-503. [PMID: 32765063 DOI: 10.2147/CMAR.S251427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Ho CM, Hu RH, Wu YM, Ho MC, Lee PH. Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation. Clin Med Insights Oncol 2020;14:1179554920968774. [PMID: 33343205 DOI: 10.1177/1179554920968774] [Reference Citation Analysis]
48 Xie QH, Zheng JQ, Ding JY, Wu YF, Liu L, Yu ZL, Chen G. Exosome-Mediated Immunosuppression in Tumor Microenvironments. Cells 2022;11:1946. [PMID: 35741075 DOI: 10.3390/cells11121946] [Reference Citation Analysis]
49 Wang S, Lv Q, Li X, Omri A. Recent Advances in Drug Delivery Nanocarriers for Targeting Hepatocellular Carcinoma. Journal of Nanomaterials 2022;2022:1-8. [DOI: 10.1155/2022/7798919] [Reference Citation Analysis]
50 Hu J, Wang Z, Wang J, Jian Y, Dai J, Wang X, Xiong W. MicroRNA-182 Promotes Cell Migration by Targeting Programmed Cell Death 4 in Hepatocellular Carcinoma Cells. Onco Targets Ther 2020;13:9159-67. [PMID: 32982304 DOI: 10.2147/OTT.S258251] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Guo W, Li Y, Pang W, Shen H. Exosomes: A Potential Therapeutic Tool Targeting Communications between Tumor Cells and Macrophages. Mol Ther 2020;28:1953-64. [PMID: 32563274 DOI: 10.1016/j.ymthe.2020.06.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]